Aclaris Therapeutics, Inc. (ACRS)

Aclaris Therapeutics Statistics

Total Valuation

ACRS has a market cap or net worth of $152.68 million. The enterprise value is -$35.36 million.

Market Cap	152.68M
Enterprise Value	-35.36M

Important Dates

The last earnings date was Thursday, May 8, 2025, before market open.

Earnings Date	May 8, 2025
Ex-Dividend Date	n/a

Share Statistics

ACRS has 108.28 million shares outstanding. The number of shares has increased by 27.19% in one year.

Current Share Class	108.28M
Shares Outstanding	108.28M
Shares Change (YoY)	+27.19%
Shares Change (QoQ)	+28.42%
Owned by Insiders (%)	2.67%
Owned by Institutions (%)	53.06%
Float	67.09M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.15
Forward PS	29.06
PB Ratio	1.06
P/TBV Ratio	1.06
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 5.06, with a Debt / Equity ratio of 0.02.

Current Ratio	5.06
Quick Ratio	4.91
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -91.03% and return on invested capital (ROIC) is -23.19%.

Return on Equity (ROE)	-91.03%
Return on Assets (ROA)	-18.20%
Return on Invested Capital (ROIC)	-23.19%
Return on Capital Employed (ROCE)	-30.68%
Revenue Per Employee	$277,766
Profits Per Employee	-$2.03M
Employee Count	64
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.03% in the last 52 weeks. The beta is 0.43, so ACRS's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	+27.03%
50-Day Moving Average	1.34
200-Day Moving Average	1.90
Relative Strength Index (RSI)	58.19
Average Volume (20 Days)	665,674

Short Selling Information

The latest short interest is 4.57 million, so 4.22% of the outstanding shares have been sold short.

Short Interest	4.57M
Short Previous Month	4.45M
Short % of Shares Out	4.22%
Short % of Float	6.81%
Short Ratio (days to cover)	4.99

Income Statement

In the last 12 months, ACRS had revenue of $17.78 million and -$130.21 million in losses. Loss per share was -$1.45.

Revenue	17.78M
Gross Profit	-32.68M
Operating Income	-54.18M
Pretax Income	-59.05M
Net Income	-130.21M
EBITDA	-53.99M
EBIT	-54.18M
Loss Per Share	-$1.45

Balance Sheet

The company has $105.31 million in cash and $2.48 million in debt, giving a net cash position of $188.04 million or $1.74 per share.

Cash & Cash Equivalents	105.31M
Total Debt	2.48M
Net Cash	188.04M
Net Cash Per Share	$1.74
Equity (Book Value)	144.07M
Book Value Per Share	1.33
Working Capital	87.28M

Cash Flow

In the last 12 months, operating cash flow was -$12.32 million and capital expenditures -$29,000, giving a free cash flow of -$12.35 million.

Operating Cash Flow	-12.32M
Capital Expenditures	-29,000
Free Cash Flow	-12.35M
FCF Per Share	-$0.11

Margins

Gross Margin	-183.84%
Operating Margin	-304.78%
Pretax Margin	-732.46%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ACRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.19%
Shareholder Yield	-27.19%
Earnings Yield	-85.28%
FCF Yield	-8.09%

Analyst Forecast

The average price target for ACRS is $9.71, which is 588.65% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$9.71
Price Target Difference	588.65%
Analyst Consensus	Strong Buy
Analyst Count	8
Revenue Growth Forecast (5Y)	35.94%
EPS Growth Forecast (5Y)	-10.18%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ACRS has an Altman Z-Score of -5.02 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.02
Piotroski F-Score	2